PhoenixBio Co Ltd (6190)

Currency in JPY
338.0
-3.0(-0.88%)
Delayed Data·
Advertisement
6190 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
338.0341.0
52 wk Range
321.0724.0
Key Statistics
Bid/Ask
337.00 / 340.00
Prev. Close
341
Open
338
Day's Range
338-341
52 wk Range
321-724
Volume
3.6K
Average Volume (3m)
7.29K
1-Year Change
-15.2882%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
6190 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
14/08/2026
EPS / Forecast
-22.38 / --
Revenue / Forecast
258M / --
EPS Revisions
Last 90 days

Compare 6190 to Peers and Sector

Metrics to compare
6190
Peers
Sector
Relationship
P/E Ratio
91.7x12.9x−0.4x
PEG Ratio
0.900.000.00
Price/Book
0.9x1.5x2.6x
Price / LTM Sales
1.0x1.7x3.1x
Upside (Analyst Target)
-86.2%49.4%
Fair Value Upside
Unlock12.6%6.8%Unlock

PhoenixBio Co., Ltd. provides contract testing services for medical product development in Japan, the United States, and internationally. The company offers PXB-mouse, a chimeric mouse with a humanized liver used in drug development experiments; and PXB-cells, human hepatocytes for in vitro studies and experiments, as well as HBV study services. Its products are used in gene therapeutics, MASH/MAFLD, viral hepatitis, DMPK/toxicity, and custom transplantations applications. The company was founded in 2002 and is headquartered in Higashihiroshima, Japan.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
1.81M44.59%617.02M
Public Companies & Retail Investors
2.26M55.41%766.85M
Total
4.07M100.00%1.38B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Sanwa Starch Co., Ltd.31.33%1,275,218433,574
Institute Of Immunology Co. Ltd3.17%129,00043,860

FAQ

What Is the PhoenixBio Co (Tokyo: 6190) Share Price Today?

The PhoenixBio Co stock price today is 338.0 JPY.

What Stock Exchange Does PhoenixBio Co (6190) Trade On?

PhoenixBio Co is listed and trades on the Tokyo Stock Exchange.

What Is the Ticker (Stock Symbol) for PhoenixBio Co?

The stock symbol (also called a 'ticker') for PhoenixBio Co is "6190."

What Is the Current PhoenixBio Co Market Capitalisation?

As of today, PhoenixBio Co (Tokyo: 6190) market cap is 1.38B JPY.

What Is PhoenixBio Co's (6190) Earnings Per Share (TTM)?

The PhoenixBio Co EPS is currently 3.7 (Trailing Twelve Months).

When Is the Next PhoenixBio Co Earnings Date?

PhoenixBio Co's next earnings report will be released on 18/11/2026.

Is 6190 a Buy or Sell From a Technical Analyst Perspective?

Based on today's PhoenixBio Co moving averages and other technical indicators, the daily buy/sell signal for 6190 stock is Strong Sell.

How Many Times Has PhoenixBio Co Stock Split?

PhoenixBio Co has split 0 times. (See the 6190 stock split history page for full effective split date and price information.)

How Many Employees Does PhoenixBio Co Have?

PhoenixBio Co has 55 employees, based on their latest Companies House report.

What is the current trading status of PhoenixBio Co (Tokyo: 6190)?

As of 01/09/2026, PhoenixBio Co (6190) is trading at a share price of 338.0 JPY, with a previous close of 341.0 JPY. The stock has fluctuated within a day range of 338.0 JPY to 341.0 JPY, while its 52-week range spans from 321.0 JPY to 724.0 JPY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.